All Medicines and Healthcare Products Regulatory Agency articles – Page 4
-
Expert BriefingThe Integrator: How quickly is general practice reforming?
What NHS England isn’t telling you, and more indispensable insight for commissioners. This week by HSJ primary care and community services correspondent Rebecca Thomas.
-
Expert BriefingThe Integrator: "Loaded gun" medicine plans may richochet back onto government
What NHS England isn’t telling you, and more indispensable insight for commissioners. This week by HSJ commissioning correspondent Sharon Brennan
-
NewsMinisters to ask drug companies to stockpile six weeks of medication
Drug companies are due to be asked to stockpile up to six weeks of medications ahead of a potential no deal Brexit, HSJ understands.
-
NewsBrexit stockpiling will face 'serious issues' and huge costs
s 3There are likely to be “serious issues” with the government’s plan to stockpile drugs and medical devices in case of a no-deal Brexit, according to senior figures in the pharmaceutical industry.
-
NewsBetter evidence needed before deploying digital medicine - review lead
A major review of new technologies and workforce in the NHS will “come down hard” in favour of stronger evidence before new digital treatments are rolled out, the lead reviewer told HSJ.
-
NewsMedical apps to face new scrutiny, amid criticism of "fragmentation"
The rapid growth in medical apps will come under stricter regulatory scrutiny amid criticism that the current system is “fragmented”.
-
NewsLord Darzi appointed chair of new innovation panel
Former health minister Lord Darzi has been appointed chair of a new innovation panel which will choose which “transformative” medical products should be fast tracked into the NHS.
-
NewsSafety regulators reviewing concerns about Babylon's 'chatbot'
Safety regulators are reviewing concerns raised about Babylon Healthcare’s symptom checker “chatbot” following multiple complaints, HSJ has learned.
-
NewsNHS hit by seven-fold increase in bill for certain drugs
NHS commissioners were hit by a seven-fold increase in the bill for certain generic drugs in 2017-18, after some medicines were subject to massive price hikes.
-
HSJ LocalFour trusts looking into pharmacy joint venture
Trusts in Berkshire and Surrey are looking at creating a pharmacy joint venture modelled on their existing pathology service.
-
NewsRevealed: Eight-fold increase in DH 'exit package' payments
The Department of Health and its executive agencies spent £39m on “exit packages” last year, following the departure of more than 700 staff.
-
CommentTurbo charging AHSNs to spread health innovations
Liz Mear on how AHSNs will leverage new funding to locally assess the benefits of new technologies and support NHS uptake of those that deliver real benefits to patients
-
HSJ LocalKeogh unveils safety steps after patient dies from drinking alcohol gel
NHS England’s medical director is considering new safety measures for acute trusts after a patient died from drinking alcohol rub.
-
NewsCCGs spending millions on drug that 'kills people'
The NHS is spending millions in prescriptions of a drug which is regarded as unsafe and was withdrawn from the UK market over 10 years ago, HSJ has been told.
-
NewsNHS England warns of heart surgery infection risk
NHS England says patients will be warned they could be at low risk Twenty-eight known cases of mycobacterium chimaera infection including 15 people who have died Infection risk identified in other countries linked to heater/cooler devices NHS England is writing to thousands of patients who have had open ...
-
NewsHigh Court rules against regulator in pharma transparency case
A High Court judge has concluded that the Health Research Authority acted unlawfully in applying new transparency rules on pharmaceutical companies carrying out clinical trials.
-
-
NewsMaking NICE guidelines mandatory ‘counterproductive’, says former chair
The National Institute for Health and Care Excellence’s former chair Sir Michael Rawlins has criticised NHS commissioners for ‘poorly implementing’ the body’s guidelines but said making them mandatory would be ‘counterproductive’.
-
NewsMHRA introduces early access scheme
Severely-ill patients will soon have access to new medicines years before they are given the green light for widespread use.
- Previous Page
- Page1
- Page2
- Page3
- Page4
- Next Page